Molesafe

Molesafe focuses on advanced skin cancer detection and prevention, utilizing innovative technologies for comprehensive skin surveillance and early disease identification. Their services cater to health-conscious individuals and healthcare providers for proactive management of skin health. Molesafe, founded in 2007, is based in Freehold, US, specializing in skin cancer detection services. The company has not undergone any notable pivots or changes in strategy since its inception.

The leadership team includes CEOs Donald Napier and Kevin Sheridan. In November 2017, MidCap Equity Partners, LLC, along with company management, invested in the company, although financial terms were not disclosed and the total amount raised during this round is not specified. MoleSafe specializes in advanced skin cancer detection and prevention services, focusing on early identification and monitoring of skin changes. The company offers skin surveillance technologies, including Total Body Photography and Dermoscopy, to capture comprehensive images of the skin and identify suspicious lesions.

Their AI-backed platform analyzes changes in shape, size, color, and location over time, ensuring thorough evaluations for individuals at high risk for skin cancer or proactive about their health. Molesafe primarily serves clients in the United States and collaborates with healthcare providers for patient evaluations. MoleSafe generates revenue through its diagnostic services offered directly to consumers and healthcare providers. Clients typically engage with MoleSafe for skin evaluations utilizing advanced imaging techniques.

Payment structures for these services are transaction-based, covering individual evaluations or packages that may include follow-up assessments and reports. Detailed reports, including recommendations for ongoing care, are provided to both patients and their primary healthcare providers, facilitating coordinated care. While specific pricing plans are not disclosed, the services are positioned as premium offerings in dermatology, targeting clients who value early detection and monitoring of skin health. Molesafe aims to expand its service offerings and reach new markets following the recent investment in November 2017.

The company is in the process of designing new products to enhance its skin surveillance capabilities, although specific release dates are not yet available. Molesafe plans to target both domestic and international markets for expansion, focusing on regions with high incidences of skin cancer. Funding from the 2017 investment will support these initiatives, although precise allocation details have not been disclosed.